Celldex Therapeutics News

Celldex Therapeutics | 10-Q: Quarterly report

May 6 16:13 ET

Celldex Therapeutics | 8-K: Celldex Reports First Quarter 2024 Financial Results and Provides Corporate Update

May 6 16:07 ET

Celldex Therapeutics | ARS: Annual Report to Security Holders

Apr 25 16:11 ET

Celldex Therapeutics | DEF 14A: Definitive information statements

Apr 25 08:05 ET

Celldex Therapeutics | 8-K: Current report

Mar 1 16:11 ET

Celldex Therapeutics | 424B5: Prospectus

Mar 1 16:10 ET

Celldex Therapeutics | 424B5: Prospectus

Feb 28 16:17 ET

Celldex Therapeutics | 424B5: Prospectus

Feb 26 08:20 ET

Celldex Therapeutics | 10-K: Annual report

Feb 26 07:10 ET

Celldex Therapeutics | 8-K: Celldex Reports Fourth Quarter and Year End 2023 Financial Results and Provides Corporate Update

Feb 26 07:05 ET

Celldex Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Jimenez Freddy A.

Feb 15 16:11 ET

Celldex Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Point72 Asset Management, L.P.(5.0%),Point72 Capital Advisors, Inc.(5.0%), etc.

Feb 14 16:26 ET

Celldex Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-Kynam Capital Management, LP(5.5%),Kynam Capital Management GP, LLC(5.5%), etc.

Feb 14 12:58 ET

Celldex Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-Eventide Asset Management, LLC(6.64%),Finny Kuruvilla, M.D. Ph. D.(6.64%), etc.

Feb 14 11:52 ET

Celldex Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-RTW Investments, LP(6.3%),Roderick Wong, M.D.(6.3%)

Feb 14 07:41 ET

Celldex Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-The Vanguard Group(5.57%)

Feb 13 17:07 ET

Celldex Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-Polar Capital Holdings Plc(5.73%),Polar Capital LLP(5.73%)

Feb 13 09:45 ET

Celldex Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-FMR LLC(12.891%),Abigail P. Johnson(12.891%)

Feb 9 08:57 ET

Celldex Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Wellington Management Group LLP(11.84%),Wellington Group Holdings LLP(11.84%), etc.

Feb 8 10:15 ET

Celldex Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-BlackRock, Inc.(6.7%)

Jan 26 17:32 ET